In contrast to
pilocytic astrocytomas(PAs), pilomyxoid
astrocytomas(PMAs)demonstrate monophasic piloid cells with angiocentric distribution and a more aggressive
clinical course. Recently, several reports have described combined histological features of both subtypes;accordingly, these were termed intermediate pilomyxoid
tumors(IPTs). The KIAA1549-BRAF fusion gene has been found in approximately 70% of PAs, but is reportedly rare in PMAs. We describe a clinicopathological study of two patients with pilomyxoid-spectrum
astrocytoma(
PMSA). Case 1 was of a 29-year-old man who presented with a
generalized seizure.
Gadolinium-magnetic resonance imaging(Gd-MRI)demonstrated a less enhanced
tumor in the left temporal lobe. Case 2 was of a 9-year-old boy who presented with
headache. Gd-MRI revealed an irregularly enhanced
tumor in the left cerebellum. In Case 1, the
tumor showed monomorphous bipolar cells in a myxoid background and angiocentric arrangement;therefore, the diagnosis was PMA. In Case 2, part of the
tumor had a myxoid, angiocentric pattern characteristic of PMA;the other part had a biphasic pattern characteristic of PA. PMA and PA were mixed in
a 7:3 ratio;therefore, IPT was diagnosed. No BRAF V600E mutations were found by immunohistochemistry and sequencing in either case. Three major KIAA1549-BRAF fusion subtypes were analyzed by quantitative reverse transcription polymerase chain reaction(RT-PCR)and sequencing. No fusions were found in Case 1. However, K16-B9 fusion was identified in Case 2, and this fusion was more prevalent in the PA component than in the PMA component. In summary, no BRAF V600E mutations were found in PMSAs, but KIAA1549-BRAF fusion was identified in IPT, particularly in the PA component.